OEL Fastrac Catalog

Please note, this OEL/ADE monograph also applies to triamcinolone acetonide (CAS RN 76-25-5), triamcinolone benetonide (CAS RN 31002-79-6), triamcinolone furetonide (CAS RN 4989-94-0), triamcinolone diacetate (CAS RN 67-78-7), and triamcinolone hexacetonide (CAS RN 5611-51-8). Triamcinolone acetonide is the acetonide salt form of triamcinolone, a synthetic glucocorticosteroid with immunosuppressive and anti-inflammatory activity. Triamcinolone is indicated for adrenal insufficiency, allergic rhinitis, seasonal or perennial asthma, carditis (acute), rheumatic carditis, disorder of endocrine system, disorder of eye, disorder of gastrointestinal tract, disorder of hematopoietic structure, disorder of respiratory system, disorder of skin, drug allergy, acute exacerbation of multiple sclerosis, inflammatory disorder of musculoskeletal system, neoplastic disease, nephrotic syndrome (idiopathic or lupus erythematosus-induced), systemic lupus erythematosus, transfusion reaction due to serum protein reaction, trichinosis with neurologic or myocardial involvement, adjunct treatment of tuberculosis of meninges, acquired hemolytic anemia, allergic rhinitis (perennial or seasonal), asthma, collagen disease, disorder of endocrine system, ganglion and synovial cyst, adjunct treatment for inflammatory disorder of musculoskeletal system, leukemia, malignant lymphoma, stomatitis, alopecia areata, and arthritis.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Triamcinolone, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.